Skip to content

Supervalu’s second quarter sales up, profits down

EDEN PRAIRIE, Minn. — Supervalu Inc. said profits fell by nearly 23% to $31 million in its fiscal second quarter, in line with analysts’ expectations.

Supervalu Inc. said profits fell by nearly 23% to $31 million in its fiscal second quarter, in line with analysts’ expectations.

Supervalu said results reflect $1 million in costs related to two breaches of customer payment-card data at stores from Virginia to Illinois earlier this year. Breach-related costs are likely to rise, the company said.

Second quarter revenue was $4 billion, up 1.8% and slightly ahead of Wall Street projections. Same-store sales at its Save-A-Lot discount supermarket chain rose 6.5% in the quarter, while same-store sales at the company’s retail food division increased by 0.4%.

Save-A-Lot posted sales of $1.05 billion in the quarter, up from $972 million a year ago, the company said. The company has 1,332 Save-A-Lot stores.

Sales at its retail food stores were $1.10 billion, up from $1.07 billion a year earlier.

"The investments we have made at Save-A-Lot continue to drive sales, and our retail food stores recorded their third consecutive quarter of positive identical-store sales," said Sam Duncan, Supervalu’s president and chief executive officer.

Last year the company sold off some of its largest supermarket banners — Albertsons, Jewel-Osco, Acme Markets, Shaw’s/Star Market — and eliminated more than one-fifth of its corporate headquarters jobs to better focus on Save-A-Lot and smaller regional chains such as Cub Foods, Shop ’n Save and Hornbacher’s.

The company also operates a wholesale distribution business that supplies 1,807 independently operated stores nationwide with branded and private label merchandise.

Latest

CRN welcomes new member companies

CRN welcomes new member companies

“CRN continues to attract companies that are committed to advancing science, quality, and responsible innovation throughout the dietary supplement supply chain,” said Steve Mister, president and CEO of CRN.